NCT01755897View on ClinicalTrials.gov

A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2020

Conditions
Uterine Cervical NeoplasmsCervical CancerUterine Cervical Cancer
Interventions
PROCEDURE

radical hysterectomy + pelvic lymph node dissection

DRUG

Paclitaxel

135-175 mg/m(2) intravenously (IV) on day 1

DRUG

Cisplatin

75 mg/m(2) IV on day 2 and 3

DRUG

Cisplatin

35 mg/m(2) IV once a week

RADIATION

Pelvic RT

IMRT

Trial Locations (3)

250012

Qilu Hospital, Shandong University, Jinan

310006

Women's Hospital, School of Medicine, Zhejiang University, Hangzhou

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
collaborator

Zhejiang University

OTHER

collaborator

Shandong University

OTHER

lead

Huazhong University of Science and Technology

OTHER

NCT01755897 - A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients | Biotech Hunter | Biotech Hunter